Exploring the Risks of GLP-1 Agonists on Pancreatitis and Gallbladder Health

A thorough examination of the possible dangers linked to GLP-1 agonists, emphasizing concerns such as pancreatitis, pancreatic cancer, and gallbladder complications. Despite findings from cardiovascular outcome trials not showing a heightened risk of acute pancreatitis, there is a noted increase in the likelihood of gallbladder issues, like gallstones, which might pose a risk for pancreatitis.